MedReleaf Corp. a leading Canadian manufacturer of medical-grade cannabis has announced that it has entered into an exclusive partnership in New York State with Compassionate Care Center of New YorkTM (CCCNYTM) a leading biopharmaceutical company applying to become one of five Registered Organizations authorized in New York State to serve the condition-specific palliative needs of qualifying patients with safe and accessible pharmaceutical-grade therapeutics derived from the cannabis plant.

MedReleaf has set the gold standard for the industrial production of medical-grade cannabis in North America. Its team of growers and horticulture experts will be on the ground at CCCNY's manufacturing facility Newark Greenhouse a currently-operating 10-acre greenhouse in Newark NY to ensure that New York patients have medical-grade product available to them by January 5 2016. Also on the ground in Newark will be MedReleaf's head of Quality Assurance Angelo Fefekos CTBS MLT who will assume the role of Chief Compliance...